ENST00000594059.1:c.-153G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000594059.1(ENSG00000269095):c.-153G>A variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000594059.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USHBP1 | NM_031941.4 | c.1852G>A | p.Val618Met | missense_variant | Exon 12 of 13 | ENST00000252597.8 | NP_114147.2 | |
USHBP1 | NM_001321417.2 | c.1852G>A | p.Val618Met | missense_variant | Exon 12 of 13 | NP_001308346.1 | ||
USHBP1 | NM_001297703.2 | c.1660G>A | p.Val554Met | missense_variant | Exon 11 of 12 | NP_001284632.1 | ||
USHBP1 | NR_135632.2 | n.2093G>A | non_coding_transcript_exon_variant | Exon 13 of 14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENSG00000269095 | ENST00000594059.1 | c.-153G>A | 5_prime_UTR_premature_start_codon_gain_variant | Exon 3 of 5 | 4 | ENSP00000473056.1 | ||||
USHBP1 | ENST00000252597.8 | c.1852G>A | p.Val618Met | missense_variant | Exon 12 of 13 | 1 | NM_031941.4 | ENSP00000252597.2 | ||
ENSG00000269095 | ENST00000594059.1 | c.-153G>A | 5_prime_UTR_variant | Exon 3 of 5 | 4 | ENSP00000473056.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1852G>A (p.V618M) alteration is located in exon 12 (coding exon 11) of the USHBP1 gene. This alteration results from a G to A substitution at nucleotide position 1852, causing the valine (V) at amino acid position 618 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.